Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist, discussed how artificial intelligence (AI) is revolutionizing lung cancer care by analyzing imaging data to detect malignancies and interstitial lung disease, while stressing the importance of regulation to ensure its safe and ethical use.
Artificial intelligence is playing a growing role in advancing lung cancer care, particularly in diagnostics and treatment. Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist at the Oncology Institute of Hope and Innovation, highlighted artificial intelligence's potential in analyzing imaging data, such as identifying irregularities in x-rays or computer tomography (CT) scans that may indicate malignancies, as well as detecting patterns of interstitial lung disease caused by medication or radiation.
Additionally, artificial intelligence can predict driver mutations by analyzing biopsy images, potentially eliminating the need for molecular testing. While acknowledging artificial intelligence's vast potential, Santos emphasized the importance of regulation to ensure its safe and ethical use in health care.
This transcript has been lightly edited for clarity.
Transcript
How are artificial intelligence and machine learning being used to advance lung cancer care, from diagnosis to treatment?
Well, that's another hot topic right now: artificial intelligence. Artificial intelligence can be applied anywhere in any single aspect of our life, from our daily activities, finance, agriculture, banking, and also in health care. So, again, just talking about lung cancer, artificial intelligence will have a many utilities. The recent ones that I have learned about, for example, is in the imaging setting. Artificial intelligence collects several data from thousands of imaging and artificial intelligence can predict, for example, if an irregular x-ray or CT scan a could predict that a patient may have a malignant disease ongoing and could perhaps alert the physician that to either [follow it closely] or perform a biopsy.
Another example for when [artificial intelligence is] collecting thousands of images, there is a problem that we call in lung cancer "interstitial lung disease," which basically is an inflammatory pattern. Today, there are different patterns of interstitial lung disease, and sometimes we have difficulty to seeing it because of radiation oncology or inflammation in the lung field or because of the medication that the patient is getting. And this is very important because it's very tricky [to figure out] how we are going to handle this issue with our patient. So artificial intelligence is collecting these thousands of inflammatory process in the lung that they can predict if this is secondary to the medication or secondary to radiation therapy, and that will help the clinician, again, to manage the patient.
Believe it or not, there is another technology in artificial intelligence collecting thousands and thousands of biopsies seen on a microscope and just by looking at the parent of the adenocarcinoma and how the cells look, the artificial intelligence can predict if the patient has a particular driver mutation. Amazing! So without doing a molecular testing and just by looking the pattern and the structure of the cells, [the artificial intelligence] can predict that.
So you can see how the artificial intelligence by collecting thousands of [pieces of] information can help us in the future. And this is going to be the future. However, as you heard in the news, artificial intelligence must be regulated, because in the wrong hands it can hurt people. So that's another issue that is not for us. But certainly, [artificial intelligence] has a lot of potential that, as humans, we need to be savvy about how to handle it. And [we need to figure out] how to moderate, utilize, and legislate that kind of advancement in technology in general.
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More